Skip to main content
Monday, November 16, 2026Nov 16

Judge: Treatment of Tennessee inmates with hepatitis C improving

Prison tile
Prison tile

NASHVILLE, Tenn. (AP) – A federal judge in Nashville ruled this week that Tennessee’s treatment of prisoners with hepatitis C is not grossly inadequate but warned the state to make good on its promises to treat more patients more quickly.

In a Monday ruling, U.S. District Judge Waverly Crenshaw noted that Tennessee has made a number of changes to improve treatment of the sometimes deadly disease within the past few months.

Despite the availability of antiviral drugs that often cure the disease, prisons across the country have struggled to get funding for the drugs, which cost more than $10,000 per patient. Tennessee prisons saw at least 56 hepatitis C-related prisoner deaths between 2013 and 2017.

Prisoners testified at the July trial that even after they became severely ill, and qualified for treatment under Tennessee Department of Correction rules, they were not given the crucial drugs. That’s because a committee must approve all prescriptions for the expensive antiviral medications

Around 4,700 Tennessee prisoners are known to be infected with hepatitis C, but until recently the committee only considered the cases of about eight prisoners each month. The department is now working to increase that number to 160 per month.